The Evolution of Frontline Therapy in ALK-Positive Advanced NSCLC: Which ALK TKI to Use Upfront? AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY Zweig, J., Wakelee, H. 2017; 13 (9): 32–36

View details for Web of Science ID 000419469500007